<DOC>
	<DOCNO>NCT03045484</DOCNO>
	<brief_summary>Background : Although concurrent chemoradiotherapy effective improve disease-free survival overall survival patient locally advanced nasopharyngeal carcinoma . However , oral mucositis pain evoke chemoradiotherapy reduces food intake frequently halts treatment . Thus , pain control important problem chemoradiotherapy nasopharyngeal carcinoma.We perform examine whether early induction low-dose , opioid moderate pain reduce total dose Oxycodone chemoradiotherapy , improve quality life reduce weight loss . Objective : Present clinical trial investigate early introduction opioids suppress transient increase numeric rating scale ( NRS ) score pain compare conventional treatment . Methodology : The subject recruit 130 patient hospitalized nasopharyngeal carcinoma . 130 patient divide two group , depend whether pain moderate severe opioid introduced.Differences group compare use T test protect least significant difference one-factor analysis variance . All statistical analysis perform use SPSS ( Statistic Package Social Science ) software.P-values &lt; 0.05 consider statistically significant .</brief_summary>
	<brief_title>Comparison Oxycodone Control Moderate Severe Oral Mucositis Pain Induced Chemoradiotherapy</brief_title>
	<detailed_description>Controlled-release oxycodone ( CRO ) use study . The patient keep daily record intensity pain . CRO effective 12 h , patient take twice day.The minimum oral unit CRO 10 mg tablet , minimum daily dose 20 mg . Thus , begin dose 20 mg default . When pain worsen , dose quickly titrated.When patient suffer moderate pain mouth , pharynx , larynx consent take oxycodone , oxycodone begin level moderate pain . We call mild group . In contrast , patient ask oxycodone pain reach severe level call severe group . Because patient agree use opioid point , patient classify two group , moderate severe , accord opioid introduce . Total dose oxycodone define total dose oxycodone take treatment chemoradiotherapy . Pain Remission Rate define pain remission 24h start opioid administration.Evaluating quality life conduct every two weeks.We also evaluate weight loss parameter food intake week , radiotherapy.All statistical analysis perform use SPSS software .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>• Age 18 65 year . Patients gender must willing practice birth control time enrollment study . Participants treatment Chemoradiotherapy advance Nasopharyngeal carcinoma . Participants ability assess pain level . Never use opioid treatment . Hematology : WBC≥4.0×109/L , ANC≥1.5×109/L , PLT≥100×109/L , Hb≥90g/L . •Patients conform inclusion criterion . Refuse use opioid drug . Nasopharyngeal patient mental illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>nasopharyngeal carcinoma</keyword>
	<keyword>Oral Mucositis Pain</keyword>
	<keyword>Oxycodone</keyword>
</DOC>